Altimmune
ALT
ALT
21 hedge funds and large institutions have $2.47M invested in Altimmune in 2019 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2.86% less ownership
Funds ownership: 10.55% → 7.69% (-2.9%)
24% less capital invested
Capital invested by funds: $3.24M → $2.47M (-$774K)
Holders
21
Holding in Top 10
–
Calls
$214K
Puts
$143K
Top Buyers
| 1 | +$309K | |
| 2 | +$262K | |
| 3 | +$119K | |
| 4 |
BlackRock
New York
|
+$86.6K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$84.5K |
Top Sellers
| 1 | -$759K | |
| 2 | -$369K | |
| 3 | -$317K | |
| 4 |
Squarepoint
New York
|
-$29.3K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$21.2K |